Home / Auditor changes / Liminatus Pharma, Inc.
Filed 2025-05-06 路 Form 8-K 路 Accession 0001104659-25-045127 micro
Price before filing: $360 (2025-05-05 close, split/dividend-adjusted)
Market cap at flag: $128.2M (2025-05-06) 路 Latest: $1.4M (2026-10-16)
| Window | LIMN | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +241.7% | +5.2% | +236.4% | 2025-06-05 |
| 90 days | -29.3% | +12.3% | -41.6% | 2025-08-04 |
| 180 days | -81.7% | +22.0% | -103.6% | 2025-11-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Upon the consummation of the Business Combination, the Company appointed WithumSmith+Brown, PC ("Withum") as the Company's independent registered public accounting firm to audit the Company's consolidated financial statements as of and for the year ending December 31, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: routine (post-merger auditor consolidation)
Disagreements reported: no
Why this score: routine: auditor replaced after company merger/SPAC deal; also within 90 days: Going-concern doubt, Late quarterly report (NT 10-Q)
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.